Maps (MAPS) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
25 Sep, 2026Structural transformation and business focus
Shift from project-based to product-based revenues, with core revenues showing a CAGR of 10% from 2020 and underlying product revenues growing at a 25% CAGR.
Strategic focus on scalable software products for healthcare and energy, leveraging proprietary platforms to expand recurring revenues.
System integration projects now serve mainly to support customer relationships and feed the product development pipeline.
Healthcare segment performance and innovation
Digital healthcare products enhance patient experience, operational efficiency, and data-driven decision-making, serving both public and private hospitals.
Patient experience solutions are used by 20% of public hospitals and all of Italy's five largest private groups.
Platforms support analogical, phygital, and digital patient journeys, covering all touchpoints from pre-visit to post-visit.
AI-driven governance tools enable cost efficiency, interoperability, and real-time performance monitoring across healthcare systems.
Healthcare leads growth, accounting for 69% of 2025 product revenues, with a 24% increase vs. 2024.
Energy segment performance and digital enablement
Proprietary BRAINWATT platform enables data-driven energy management, reducing costs and emissions while optimizing asset value.
Solutions serve real estate, industry, utilities, and public administration, with notable clients like BNP Paribas Real Estate and SEA Milan Airports.
Use cases demonstrate significant annual savings in healthcare, plastics, and food & beverage sectors.
Energy products represent 9% of 2025 revenues, with a modest 10% growth vs. 2024.
Latest events from Maps
- Recurring fees and digitalization drive growth, but net profit falls on higher costs.MAPS
H1 2026 - Product-driven growth in healthcare offset project declines; EBITDA and profit margins narrowed.MAPS
H2 2025 - Healthcare-led product growth and Ellysse acquisition drive strategy as net profit dips.MAPS
H1 2025 - Digital transformation in healthcare and energy drives robust growth and strong future outlook.MAPS
Investor Presentation - 2024 saw record profitability, strong product-driven growth, and a robust outlook to 2027.MAPS
Investor Presentation - Record profitability and product-driven growth position the group for further expansion.MAPS
Investor Presentation - Profitability surged over 50% in H1 2024, with revenues up to €14.7M and improved cash flow.MAPS
H1 2024 - Record profitability and cash flow growth driven by scalable products and healthcare strength.MAPS
H2 2024